Septerna (SEPN) IPO deck
Septerna is a biotechnology company focused on developing orally available small molecule drugs that target G protein-coupled receptors (GPCRs).
Septerna is a biotechnology company focused on developing orally available small molecule drugs that target G protein-coupled receptors (GPCRs).
%20IPO%20deck){kind=link}